INDIANAPOLIS, May 13, 2011 /PRNewswire/ -- BioStorage Technologies will host its half-day Global Sample Management Benchmarking Symposium in conjunction with its new facility opening in Indianapolis on May 26, 2011, from 1:30 p.m. EDT to 4:30 p.m. (5:30 p.m. 8:30 p.m. GMT). The symposium will provide insight into some of the most critically important facets of sample management, including: new trends in outsourcing, growth in unique insourcing methods, advancements in the biopreservation of samples, new methods and processes for the management of biomarkers and genomic testing in clinical studies.
Recent advances in molecular technology and genomic discoveries, coupled with the growth in clinical research, have increased the need for properly preserved biospecimens. As this need continues to grow, it has become imperative to spearhead discussions on innovative techniques and best practices for the storage and preservation of samples to ensure that current and future discovery is not jeopardized.
“Samples are often the foundation of today’s novel drug discovery and can be an accelerator of tomorrow’s medical breakthroughs,” said Gregory Swanberg, Chief Executive Officer, BioStorage Technologies. “BioStorage Technologies is committed to not only being the leader in comprehensive sample management, but we also strive to be an information resource to help advance the entire biobanking community.”
Attendees will have the opportunity to network with colleagues and receive insights on how to leverage and protect scientific sample assets from a panel of experts.
The speaker line up includes:
- Rakesh Kishan, President and CEO of UMS Advisory, Inc.
“A Focus on the Future Trends in Biopharmaceutical Outsourcing” - Dr. Allison Hubel, Professor, University of Minnesota and BioCor Director
“New Methods and Best Practices for Improving the Biopreservation of Research Samples” - Steve Sweeney, Director of Clinical Operations, Infinity Pharmaceuticals, Inc.
“Strategies for Improving the Onsite Management of Scientific Sample Assets” - Dr. Daniel H. Farkas, Laboratory Director, Sequenom Center for Molecular Medicine and VP, Clinical Diagnostics, Sequenom
“Molecular Diagnostics in the Genomic Era: A Q&A Session”
“Due to the lack of FDA regulations for sample management and differences in global policies, it is imperative the industry joins together to discuss common guidelines for these invaluable assets,” said Lori A. Ball, Chief Operating Officer, BioStorage Technologies. “This is of the upmost importance as we understand that samples stored today will be held to the standards of tomorrow.”
BioStorage Technologies will continue to provide an open environment for the industry to come together by listening to and addressing the needs of researchers and scientists around the world. Most recently, BioStorage Technologies hosted a half-day symposium in partnership with the Biorepositories Asia Conference, which focused on new trends in international sample management, specifically in Asia.
For more information, or to register for the Global Sample Management Symposium, visit www.biostoragesymposium.com
About BioStorage Technologies, Inc.:
BioStorage Technologies Inc. is the global leader in comprehensive scientific sample asset management and onsite solutions for the bioscience industry. Offering a team of sample experts, state-of-the-art temperature-controlled storage facilities, a real-time, web-based sample intelligence and tracking, BioStorage Technologies manages the complete life-cycle of sample assets enabling companies to maximize opportunities, minimize risk and reduce costs. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.comor call +1 (866) 697-2675 or +49-6155-898-1011.
Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com
SOURCE BioStorage Technologies
